375 related articles for article (PubMed ID: 29529885)
1. Palliative Chemotherapy Near the End of Life in Oncology Patients.
Zhang Z; Chen ML; Gu XL; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2018 Sep; 35(9):1215-1220. PubMed ID: 29529885
[TBL] [Abstract][Full Text] [Related]
2. Use of Palliative Chemo- and Radiotherapy at the End of Life in Patients With Cancer: A Retrospective Cohort Study.
Zhang Z; Gu XL; Chen ML; Liu MH; Zhao WW; Cheng WW
Am J Hosp Palliat Care; 2017 Nov; 34(9):801-805. PubMed ID: 27281134
[TBL] [Abstract][Full Text] [Related]
3. Use of palliative chemotherapy near the end of life: a retrospective cohort study.
Zhang Z; Chen ML; Gu XL; Cheng WW
Ann Palliat Med; 2020 Sep; 9(5):2809-2816. PubMed ID: 32787344
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy Near the End of Life for Chinese Patients with Solid Malignancies.
Sheng J; Zhang YX; He XB; Fang WF; Yang YP; Lin GN; Wu X; Li N; Zhang J; Zhai LZ; Zhao YY; Huang Y; Zhou NN; Zhao HY; Zhang L
Oncologist; 2017 Jan; 22(1):53-60. PubMed ID: 27789776
[TBL] [Abstract][Full Text] [Related]
5. End-of-life Care Among Gynecological Oncology Patients in a Single Institute in Israel.
Shapiro S; Lavie O; Schmidt M; Ben Arya E; Dagash J; Yosipovich A; Segev Y
Isr Med Assoc J; 2021 Sep; 23(9):556-562. PubMed ID: 34472230
[TBL] [Abstract][Full Text] [Related]
6. Palliative Chemotherapy Affects Aggressiveness of End-of-Life Care.
Wu CC; Hsu TW; Chang CM; Lee CH; Huang CY; Lee CC
Oncologist; 2016 Jun; 21(6):771-7. PubMed ID: 27091417
[TBL] [Abstract][Full Text] [Related]
7. Palliative care needs, symptoms, and treatment intensity along the disease trajectory in medical oncology outpatients: a retrospective chart review.
Bükki J; Scherbel J; Stiel S; Klein C; Meidenbauer N; Ostgathe C
Support Care Cancer; 2013 Jun; 21(6):1743-50. PubMed ID: 23344656
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy and targeted therapy near the end of life affects aggressiveness of palliative care.
Zhang Z; Chen ML; Liu MH; Cheng WW
Ann Palliat Med; 2021 Mar; 10(3):2917-2925. PubMed ID: 33549022
[TBL] [Abstract][Full Text] [Related]
9. Predictors of symptoms and site of death in pediatric palliative patients with cancer at end of life.
Schindera C; Tomlinson D; Bartels U; Gillmeister B; Alli A; Sung L
Am J Hosp Palliat Care; 2014 Aug; 31(5):548-52. PubMed ID: 23901145
[TBL] [Abstract][Full Text] [Related]
10. High-intensity end-of-life care among children, adolescents, and young adults with cancer who die in the hospital: A population-based study from the French national hospital database.
Revon-Rivière G; Pauly V; Baumstarck K; Bernard C; André N; Gentet JC; Seyler C; Fond G; Orleans V; Michel G; Auquier P; Boyer L
Cancer; 2019 Jul; 125(13):2300-2308. PubMed ID: 30913309
[TBL] [Abstract][Full Text] [Related]
11. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
Chen ML; Chen YY; Tang ST
Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
[TBL] [Abstract][Full Text] [Related]
12. Association between palliative care and end-of-Life care for patients with hematological malignancies: A population-based study.
Chiang JK; Lee YC; Kao YH
Medicine (Baltimore); 2019 Oct; 98(40):e17395. PubMed ID: 31577748
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care.
Bylicki O; Rivière F; Tournier C; Canoui-Poitrine F; Grassin F; Margery J; Prodel M; Vainchtock A; Assié JB; Chouaïd C
Clin Lung Cancer; 2021 May; 22(3):e320-e328. PubMed ID: 32646653
[TBL] [Abstract][Full Text] [Related]
14. Use of chemotherapy near the end of life: what factors matter?
Rochigneux P; Raoul JL; Beaussant Y; Aubry R; Goldwasser F; Tournigand C; Morin L
Ann Oncol; 2017 Apr; 28(4):809-817. PubMed ID: 27993817
[TBL] [Abstract][Full Text] [Related]
15. Administration of chemotherapy with palliative intent in the last 30 days of life: the balance between palliation and chemotherapy.
Zdenkowski N; Cavenagh J; Ku YC; Bisquera A; Bonaventura A
Intern Med J; 2013 Nov; 43(11):1191-8. PubMed ID: 23870085
[TBL] [Abstract][Full Text] [Related]
16. Characteristics and Correlates of Increasing Use of Surgery in Taiwanese Cancer Patients' Last Month of Life, 2001-2010.
Liu TW; Hung YN; Earle CC; Liu TP; Liu LN; Tang ST
Ann Surg; 2016 Aug; 264(2):283-90. PubMed ID: 26655921
[TBL] [Abstract][Full Text] [Related]
17. Utilization of systemic palliative chemotherapy at the end of life: a local experience.
Abdul Monem E; Mehdi I; Al Bahrani BJ; Nada AM; Al Kharusi S
J Pak Med Assoc; 2014 Aug; 64(8):863-8. PubMed ID: 25252508
[TBL] [Abstract][Full Text] [Related]
18. End-of-life chemotherapy is associated with poor survival and aggressive care in patients with small cell lung cancer.
Zhu Y; Tang K; Zhao F; Zang Y; Wang X; Li Z; Sun X; Yu J
J Cancer Res Clin Oncol; 2018 Aug; 144(8):1591-1599. PubMed ID: 29845418
[TBL] [Abstract][Full Text] [Related]
19. End-of-life decision-making of terminally ill cancer patients in a tertiary cancer center in Shanghai, China.
Gu X; Chen M; Liu M; Zhang Z; Cheng W
Support Care Cancer; 2016 May; 24(5):2209-2215. PubMed ID: 26567116
[TBL] [Abstract][Full Text] [Related]
20. Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.
Anshushaug M; Gynnild MA; Kaasa S; Kvikstad A; Grønberg BH
Acta Oncol; 2015 Mar; 54(3):395-402. PubMed ID: 25162953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
